AN ANTAGONIST DECOY RECEPTOR AND A DEATH DOMAIN-CONTAINING RECEPTOR FOR TRAIL

Citation
Gh. Pan et al., AN ANTAGONIST DECOY RECEPTOR AND A DEATH DOMAIN-CONTAINING RECEPTOR FOR TRAIL, Science, 277(5327), 1997, pp. 815-818
Citations number
27
Categorie Soggetti
Multidisciplinary Sciences
Journal title
ISSN journal
00368075
Volume
277
Issue
5327
Year of publication
1997
Pages
815 - 818
Database
ISI
SICI code
0036-8075(1997)277:5327<815:AADRAA>2.0.ZU;2-C
Abstract
TRAIL, also called Apo2L, is a cytotoxic protein that induces apoptosi s of many transformed cell fines but not of normal tissues, even thoug h its death domain-containing receptor, DR4, is expressed on both cell types. An antagonist decoy receptor (designated as TRID for TRAIL rec eptor without an intracellular domain) that may explain the resistant phenotype of normal tissues was identified. TRID is a distinct gene pr oduct with an extracellular TRAIL-binding domain and a transmembrane d omain but no intracellular signaling domain. TRID transcripts were det ected in many normal human tissues but not in most cancer cell lines e xamined. Ectopic expression of TRID protected mammalian cells from TRA IL-induced apoptosis, which is consistent with a protective role. Anot her death domain-containing receptor for TRAIL (designated as death re ceptor-5), which preferentially engaged a FLICE (caspase-8)-related de ath protease, was also identified.